Melissa Johnson
MD
Director, Lung Cancer Research Program
👥Biography 个人简介
Melissa Johnson has been a lead investigator in sotorasib combination trials for later-line KRAS G12C-mutant NSCLC. Her clinical research program at Sarah Cannon spans multiple KRAS-targeting strategies including combinations with anti-EGFR antibodies and chemotherapy. She has contributed to understanding optimal patient selection for KRAS-targeted therapies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Melissa Johnson 的研究动态
Follow Melissa Johnson's research updates
留下邮箱，当我们发布与 Melissa Johnson（Sarah Cannon Research Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment